Prot# A431-1002: Phs II, Dbl-Bld, Rndmzd, Plcbo Cntrl'd Study of 2 Doses of Capravirine (AG1549) in Combt'n w/ VIRACEPT? & 2 Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed an Initial Nonnucleoside Reverse Transcriptase Inh

Project: Research project

Project Details

StatusFinished
Effective start/end date8/26/024/16/07

Funding

  • Agouron Pharmaceuticals, Inc. (A431-1002)